Phonak Audiology Research Center
Aurora, Illinois, 60504, United States
NCT Number: NCT04839289
Participants will be fit with each of two hearing instruments in an ABA cross-over design. The study will consist of a total of three approximately 10-day home trials with the devices. Participants will be asked to provide qualitative feedback to investigators regarding the performance of and their preference for each hearing instrument.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
Aurora, Illinois, 60504, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Commercially available receiver-in-canal hearing instrument from manufacturer A
Commercially available receiver-in-canal hearing instrument from manufacturer B
Time frame: End of home trial 1 (Day 10 of study)
Qualitative feedback questionnaire to gather feedback on particular areas of focus. Subjects will rate hearing performance and sound quality on a Likert scale with lowest number equivalent to worst performance or worst sound quality (1) and higher number equivalent to best performance or best sound quality (10).
Time frame: End of home trial 2 (20 days after study start)
Qualitative feedback questionnaire to gather feedback on particular areas of focus. Subjects will rate hearing performance and sound quality on a Likert scale with lowest number equivalent to worst performance or worst sound quality (1) and higher number equivalent to best performance or best sound quality (10).
Time frame: End of home trial 3 (30 days after study start)
Qualitative feedback questionnaire to gather feedback on particular areas of focus. Subjects will rate hearing performance and sound quality on a Likert scale with lowest number equivalent to worst performance or worst sound quality (1) and higher number equivalent to best performance or best sound quality (10).
Time frame: End of home trial 1 (Day 10 of study)
Measures satisfaction on various aspects of hearing aid use on a scale from 1 to 5, with 1 = Very unsatisfied to 5 = Very satisfied, and 3 = Neutral.
.
Time frame: End of home trial 2 (Day 20 of study)
Measures satisfaction on various aspects of hearing aid use on a scale from 1 to 5, with 1 = Very unsatisfied to 5 = Very satisfied, and 3 = Neutral.
Time frame: End of home trial 3 (Day 30 of study)
Measures satisfaction on various aspects of hearing aid use on a scale from 1 to 5, with 1 = Very unsatisfied to 5 = Very satisfied, and 3 = Neutral.
Sonova AG
Industry
A Study to Compare Patient Perceptions of Two Different Hearing Aid Signal Processing Philosophies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06424262
Ear Diseases, Hearing Disorders
Sydney, New South Wales, Australia
View Trial DetailsNCT03686046
Ear Diseases, Hearing Disorders
San Diego, California, United States
View Trial DetailsNCT07667140
Ear Diseases, Hearing Disorders
Oldenburg, Germany
View Trial DetailsNCT06176625
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial Details